INGEVITY CORP (NGVT) Fundamental Analysis & Valuation

NYSE:NGVT • US45688C1071

Current stock price

71.41 USD
+1.85 (+2.66%)
Last:

This NGVT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. NGVT Profitability Analysis

1.1 Basic Checks

  • In the past year NGVT was profitable.
  • NGVT had a positive operating cash flow in the past year.
  • In multiple years NGVT reported negative net income over the last 5 years.
  • Each year in the past 5 years NGVT had a positive operating cash flow.
NGVT Yearly Net Income VS EBIT VS OCF VS FCFNGVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • NGVT's Return On Assets of -10.12% is on the low side compared to the rest of the industry. NGVT is outperformed by 78.31% of its industry peers.
  • NGVT has a worse Return On Equity (-562.63%) than 95.18% of its industry peers.
  • NGVT has a Return On Invested Capital of 16.53%. This is amongst the best in the industry. NGVT outperforms 98.80% of its industry peers.
  • NGVT had an Average Return On Invested Capital over the past 3 years of 12.61%. This is significantly above the industry average of 6.58%.
  • The 3 year average ROIC (12.61%) for NGVT is below the current ROIC(16.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -10.12%
ROE -562.63%
ROIC 16.53%
ROA(3y)-10.53%
ROA(5y)-3.82%
ROE(3y)-261.31%
ROE(5y)-147.22%
ROIC(3y)12.61%
ROIC(5y)12.07%
NGVT Yearly ROA, ROE, ROICNGVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400

1.3 Margins

  • NGVT has a Operating Margin of 22.15%. This is amongst the best in the industry. NGVT outperforms 90.36% of its industry peers.
  • In the last couple of years the Operating Margin of NGVT has remained more or less at the same level.
  • NGVT's Gross Margin of 38.23% is fine compared to the rest of the industry. NGVT outperforms 79.52% of its industry peers.
  • In the last couple of years the Gross Margin of NGVT has remained more or less at the same level.
Industry RankSector Rank
OM 22.15%
PM (TTM) N/A
GM 38.23%
OM growth 3Y3.28%
OM growth 5Y-1.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.97%
GM growth 5Y0.64%
NGVT Yearly Profit, Operating, Gross MarginsNGVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NGVT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NGVT is still creating some value.
  • NGVT has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NGVT has been reduced compared to 5 years ago.
  • NGVT has a worse debt/assets ratio than last year.
NGVT Yearly Shares OutstandingNGVT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NGVT Yearly Total Debt VS Total AssetsNGVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • NGVT has an Altman-Z score of 2.63. This is not the best score and indicates that NGVT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.63, NGVT is doing good in the industry, outperforming 69.88% of the companies in the same industry.
  • NGVT has a debt to FCF ratio of 4.42. This is a neutral value as NGVT would need 4.42 years to pay back of all of its debts.
  • NGVT has a better Debt to FCF ratio (4.42) than 80.72% of its industry peers.
  • NGVT has a Debt/Equity ratio of 39.10. This is a high value indicating a heavy dependency on external financing.
  • NGVT has a worse Debt to Equity ratio (39.10) than 95.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 39.1
Debt/FCF 4.42
Altman-Z 2.63
ROIC/WACC1.38
WACC11.95%
NGVT Yearly LT Debt VS Equity VS FCFNGVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • NGVT has a Current Ratio of 1.33. This is a normal value and indicates that NGVT is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.33, NGVT is not doing good in the industry: 77.11% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.79 indicates that NGVT may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.79, NGVT is doing worse than 75.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.79
NGVT Yearly Current Assets VS Current LiabilitesNGVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NGVT Growth Analysis

3.1 Past

  • NGVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.54%, which is quite impressive.
  • NGVT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.44% yearly.
  • Looking at the last year, NGVT shows a very negative growth in Revenue. The Revenue has decreased by -12.02% in the last year.
  • Measured over the past years, NGVT shows a decrease in Revenue. The Revenue has been decreasing by -0.81% on average per year.
EPS 1Y (TTM)26.54%
EPS 3Y-8.99%
EPS 5Y-1.44%
EPS Q2Q%-33.68%
Revenue 1Y (TTM)-12.02%
Revenue growth 3Y-11.21%
Revenue growth 5Y-0.81%
Sales Q2Q%-14.63%

3.2 Future

  • NGVT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.02% yearly.
  • The Revenue is expected to decrease by -1.19% on average over the next years.
EPS Next Y11.51%
EPS Next 2Y16.04%
EPS Next 3Y14.02%
EPS Next 5YN/A
Revenue Next Year-5.02%
Revenue Next 2Y-2.3%
Revenue Next 3Y-1.19%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NGVT Yearly Revenue VS EstimatesNGVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
NGVT Yearly EPS VS EstimatesNGVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. NGVT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.76 indicates a correct valuation of NGVT.
  • NGVT's Price/Earnings ratio is a bit cheaper when compared to the industry. NGVT is cheaper than 73.49% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 24.75, NGVT is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 14.14, which indicates a correct valuation of NGVT.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NGVT indicates a somewhat cheap valuation: NGVT is cheaper than 71.08% of the companies listed in the same industry.
  • NGVT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 15.76
Fwd PE 14.14
NGVT Price Earnings VS Forward Price EarningsNGVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • 71.08% of the companies in the same industry are more expensive than NGVT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, NGVT is valued cheaply inside the industry as 92.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.21
EV/EBITDA 9.42
NGVT Per share dataNGVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of NGVT may justify a higher PE ratio.
  • NGVT's earnings are expected to grow with 14.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)N/A
EPS Next 2Y16.04%
EPS Next 3Y14.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NGVT Dividend Analysis

5.1 Amount

  • NGVT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NGVT Fundamentals: All Metrics, Ratios and Statistics

INGEVITY CORP

NYSE:NGVT (3/31/2026, 3:11:30 PM)

71.41

+1.85 (+2.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-25
Earnings (Next)05-04
Inst Owners107.78%
Inst Owner Change2.09%
Ins Owners0.93%
Ins Owner Change5.21%
Market Cap2.52B
Revenue(TTM)1.24B
Net Income(TTM)-167.10M
Analysts82
Price Target80.83 (13.19%)
Short Float %3.71%
Short Ratio3.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.48%
Min EPS beat(2)-10.16%
Max EPS beat(2)7.21%
EPS beat(4)3
Avg EPS beat(4)11.47%
Min EPS beat(4)-10.16%
Max EPS beat(4)31.61%
EPS beat(8)6
Avg EPS beat(8)40.23%
EPS beat(12)8
Avg EPS beat(12)43.58%
EPS beat(16)11
Avg EPS beat(16)35.39%
Revenue beat(2)0
Avg Revenue beat(2)-6.09%
Min Revenue beat(2)-9.4%
Max Revenue beat(2)-2.79%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-9.4%
Max Revenue beat(4)-2.47%
Revenue beat(8)1
Avg Revenue beat(8)-3.9%
Revenue beat(12)2
Avg Revenue beat(12)-3.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.17%
PT rev (1m)12.01%
PT rev (3m)16.12%
EPS NQ rev (1m)-8.8%
EPS NQ rev (3m)-13.61%
EPS NY rev (1m)5.09%
EPS NY rev (3m)-1.1%
Revenue NQ rev (1m)-4.65%
Revenue NQ rev (3m)-10.04%
Revenue NY rev (1m)-3.04%
Revenue NY rev (3m)-7.14%
Valuation
Industry RankSector Rank
PE 15.76
Fwd PE 14.14
P/S 2.04
P/FCF 9.21
P/OCF 7.61
P/B 84.85
P/tB N/A
EV/EBITDA 9.42
EPS(TTM)4.53
EY6.34%
EPS(NY)5.05
Fwd EY7.07%
FCF(TTM)7.75
FCFY10.85%
OCF(TTM)9.39
OCFY13.14%
SpS35.06
BVpS0.84
TBVpS-4.27
PEG (NY)1.37
PEG (5Y)N/A
Graham Number9.26
Profitability
Industry RankSector Rank
ROA -10.12%
ROE -562.63%
ROCE 20.93%
ROIC 16.53%
ROICexc 17.58%
ROICexgc 20.6%
OM 22.15%
PM (TTM) N/A
GM 38.23%
FCFM 22.1%
ROA(3y)-10.53%
ROA(5y)-3.82%
ROE(3y)-261.31%
ROE(5y)-147.22%
ROIC(3y)12.61%
ROIC(5y)12.07%
ROICexc(3y)13.26%
ROICexc(5y)12.85%
ROICexgc(3y)18.63%
ROICexgc(5y)19.64%
ROCE(3y)15.96%
ROCE(5y)15.28%
ROICexgc growth 3Y1.74%
ROICexgc growth 5Y-1.88%
ROICexc growth 3Y13.83%
ROICexc growth 5Y6.5%
OM growth 3Y3.28%
OM growth 5Y-1.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.97%
GM growth 5Y0.64%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 39.1
Debt/FCF 4.42
Debt/EBITDA 3.05
Cap/Depr 54.23%
Cap/Sales 4.66%
Interest Coverage 3.89
Cash Conversion 87.04%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.79
Altman-Z 2.63
F-Score6
WACC11.95%
ROIC/WACC1.38
Cap/Depr(3y)71.77%
Cap/Depr(5y)88.14%
Cap/Sales(3y)6.81%
Cap/Sales(5y)7.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.54%
EPS 3Y-8.99%
EPS 5Y-1.44%
EPS Q2Q%-33.68%
EPS Next Y11.51%
EPS Next 2Y16.04%
EPS Next 3Y14.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.02%
Revenue growth 3Y-11.21%
Revenue growth 5Y-0.81%
Sales Q2Q%-14.63%
Revenue Next Year-5.02%
Revenue Next 2Y-2.3%
Revenue Next 3Y-1.19%
Revenue Next 5YN/A
EBIT growth 1Y3.12%
EBIT growth 3Y-8.3%
EBIT growth 5Y-1.86%
EBIT Next Year35.71%
EBIT Next 3Y13.85%
EBIT Next 5YN/A
FCF growth 1Y436.28%
FCF growth 3Y17.04%
FCF growth 5Y0.24%
OCF growth 1Y157.54%
OCF growth 3Y1.89%
OCF growth 5Y-1.23%

INGEVITY CORP / NGVT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INGEVITY CORP (NGVT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NGVT.


What is the valuation status for NGVT stock?

ChartMill assigns a valuation rating of 6 / 10 to INGEVITY CORP (NGVT). This can be considered as Fairly Valued.


Can you provide the profitability details for INGEVITY CORP?

INGEVITY CORP (NGVT) has a profitability rating of 6 / 10.


How financially healthy is INGEVITY CORP?

The financial health rating of INGEVITY CORP (NGVT) is 4 / 10.